XML 47 R36.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock Options and Warrants (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Stock Options and Warrants [Abstract] |
Schedule Warrants Issued and Outstanding | Options issued and outstanding as of September 30, 2025, and their activities during the period then ended are as follows:
|  |  |  |  | Weighted- |  |  | Weighted- |  |  |  |
|  |  |  |  | Average |  |  | Average |  |  |  |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  |  |
|  | Underlying Shares (post-split) |  |  | Price Per Share (post-split) |  |  | Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.74 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding as of September 30, 2025 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 6.00 |  |  | $ | - |
Exercisable as of September 30, 2025 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 6.00 |  |  | $ | - |
Vested and expected to vest |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.00 |  |  | $ | - |
Schedule Warrants Issued and Outstanding | Warrants issued and outstanding in connection with Shuling land transaction (See Note 5) as of September 30, 2025, and their activities during the nine-month period ended are as follows:
|  | Number of Underlying Shares |  |  | Weighted- Average Exercise Price Per Share |  |  | Weighted- Average Contractual Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Issued |  |  | 1,000,000 |  |  |  | 2.50 |  |  |  | 5.00 |  |  |  | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  |  | - |
Outstanding as of September 30, 2025 |  |  | 1,000,000 |  |  | $ | 2.50 |  |  |  | 4.79 |  |  | $ | 540,000 |
Warrants issued and outstanding in connection with Lind convertible notes (See Note 12) as of September 30, 2025, and their activities during the nine-month period ended are as follows:
|  | Number of Underlying Shares |  |  | Weighted- Average Exercise Price Per Share |  |  | Weighted- Average Contractual Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | 2,029,167 |  |  | $ | 0.40 | * |  |  | 4.20 |  |  | $ | 195,542 |
Issued |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (1,529,167 | ) |  | $ | 0.60 |  |  |  | - |  |  |  | - |
Outstanding as of September 30, 2025 |  |  | 500,000 |  |  | $ | 1.00 |  |  |  | 3.64 |  |  | $ | 1,020,000 |
* | On January 5, 2025, the Company and Lind entered into a third letter agreement (the “December Letter Agreement”), pursuant to which Lind agreed to exercise for cash, 1,029,167 of the Existing Warrants to purchase shares of Common Stock, with a current exercise price of $0.75 per share, at a reduced exercise price of $0.40 per share. The weighted average exercise price per share as of December 31, 2024 was adjusted to the reduction accordingly.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration